Previous Close | 0.9900 |
Open | 1.0300 |
Bid | 1.0400 x N/A |
Ask | 1.0700 x N/A |
Day's Range | 1.0000 - 1.1400 |
52 Week Range | 0.4600 - 1.7600 |
Volume | |
Avg. Volume | 71,073 |
Market Cap | 79.902M |
Beta (5Y Monthly) | 1.18 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0400 |
Earnings Date | Feb 21, 2022 - Feb 28, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 2.65 |
CALGARY, AB / ACCESSWIRE / May 2, 2022 / Nanalysis Scientific Corp. ("the Company"), (TSXV:NSCI)(OTCQX:NSCIF)(FRA:1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, today announced that it will be presenting at the Planet MicroCap Showcase 2022 at the Bally's Hotel & Casino in Las Vegas, NV on Wednesday, May 4, 2022 at 5:30 PM Pacific Time.
Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, releases its fourth quarter and full year results for year ending December 31, 2021. Chief Executive Officer, Sean Krakiwsky and Chief Financial Officer, Luke Caplette will host a conference call at 5 P.M. Eastern Time today to discuss the results. All interested parties are invited to join this call.
LOS ANGELES, CA / ACCESSWIRE / April 27, 2022 / SNN Network presents the Planet MicroCap Showcase taking place on May 3-5, 2022, where 88 MicroCap public and private companies will be presenting at Bally's Hotel & Casino in Las Vegas, NV.comThe Planet MicroCap Showcase begins on Tuesday, May 3, 2022 with the "MicroCap Investing Workshop" starting at 12:00pm PST and featuring well-known financial influencers, investors, fund managers, and key opinion leaders, followed by 88 MicroCap public and pr